跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
177Lu-PSMA-I&T
首页
药物
177Lu-PSMA-I&T
177Lu-PSMA-I&T
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
EP 4753817 A1
申请人: CURIUM US LLC
优先权: 2023
EP
US
WO
10 件公开
US 20250032651 A1
申请人: CURIUM US LLC
优先权: 2024
US
US 20250121103 A1
申请人: CURIUM US LLC
优先权: 2024
US
US 20260115337 A1
申请人: CURIUM US LLC
优先权: 2025
US
Radiopharmaceutical and methods
US 11491246 B2
申请人: POINT BIOPHARMA INC
优先权: 2021
US
WO
8 件公开
US 11129912 B1
申请人: POINT BIOPHARMA INC
优先权: 2021
US
[177LU] LUTETIUM-PSMA L&T COMPOSITION, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
EP 4561641 A2
申请人: CURIUM US LLC
优先权: 2022
EP
US
WO
4 件公开
RADIOPHARMACEUTICAL TREATMENT METHODS AND USE
EP 4440627 A1
申请人: POINT BIOPHARMA INC
优先权: 2021
EP
US
WO
3 件公开
LYOPHILIZATE, PHARMACUETICAL COMPOSITION AND METHOD FOR PREPARING SAME
WO 2025042307 A1
申请人: CENTER OF MOLECULAR RES LIMITED LIABILITY COMPANY CMR LLC
优先权: 2023
WO
Protein binding group modified dimeric PSMA diagnosis and treatment integrated probe
CN 120271658 A
申请人: THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV
优先权: 2023
CN
[177LU]LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
WO 2026019453 A1
申请人: CURIUM US LLC
优先权: 2024
WO
药物
反馈